当前位置:首页 - 行情中心 - 力生制药(002393) - 财务分析 - 现金流量表

力生制药

(002393)

  

流通市值:40.56亿  总市值:41.65亿
流通股本:3.00亿   总股本:3.08亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金568,558,992.48321,094,641.931,457,801,783.561,008,713,306.08
  收到的税费返还11,048.1130,114.2227,273.8315,589.06
  收到其他与经营活动有关的现金47,769,684.6111,159,047.26138,292,035.05113,108,957.16
  经营活动现金流入小计616,339,725.2332,283,803.411,596,121,092.441,121,837,852.3
  购买商品、接受劳务支付的现金216,601,515.01107,442,961.56411,270,616.98278,438,685.88
  支付给职工以及为职工支付的现金142,721,209.778,457,393.81280,533,714.05188,895,414.86
  支付的各项税费76,639,068.7136,948,912.02190,205,081.14160,625,209.47
  支付其他与经营活动有关的现金224,569,468.25108,445,815.71466,615,029.56369,058,945.53
  经营活动现金流出小计660,531,261.67331,295,083.11,348,624,441.73997,018,255.74
  经营活动产生的现金流量净额-44,191,536.47988,720.31247,496,650.71124,819,596.56
二、投资活动产生的现金流量:
  收回投资收到的现金1,070,495,000490,495,0003,110,464,041.672,310,230,000
  取得投资收益收到的现金46,755,676.213,435,470.13204,356,90439,226,845.85
  处置固定资产、无形资产和其他长期资产收回的现金净额--2,930,780.8943,442.08
  处置子公司及其他营业单位收到的现金净额---0
  收到的其他与投资活动有关的现金---50,000,000
  投资活动现金流入小计1,117,250,676.21493,930,470.133,317,751,726.562,399,500,287.93
  购建固定资产、无形资产和其他长期资产支付的现金9,658,932.862,756,741.637,459,304.5917,353,946.94
  投资支付的现金1,091,634,000461,634,110.143,440,575,0002,725,230,000
  取得子公司及其他营业单位支付的现金--6,991,8556,991,855
  支付其他与投资活动有关的现金0-12,50012,500
  投资活动现金流出小计1,101,292,932.86464,390,851.743,485,038,659.592,749,588,301.94
  投资活动产生的现金流量净额15,957,743.3529,539,618.39-167,286,933.03-350,088,014.01
三、筹资活动产生的现金流量:
  吸收投资收到的现金900,000-68,681,90061,104,300
  取得借款收到的现金--24,314,642.8325,000,000
  收到其他与筹资活动有关的现金1,085,993.07-1,052,017.971,052,017.97
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计1,985,993.07-94,048,560.887,156,317.97
  偿还债务支付的现金18,350,000750,00039,750,00039,750,000
  分配股利、利润或偿付利息支付的现金231,177,122.7376,759,807.0897,001,999.5197,437,481.61
  支付其他与筹资活动有关的现金6,255,425.8-95,433,152.9792,620,020.77
  筹资活动现金流出小计255,782,548.5377,509,807.08232,185,152.48229,807,502.38
  筹资活动产生的现金流量净额-253,796,555.46-77,509,807.08-138,136,591.68-142,651,184.41
四、汇率变动对现金及现金等价物的影响---2,566.09-2,566.09
五、现金及现金等价物净增加额-282,030,348.58-46,981,468.38-57,929,440.09-367,922,167.95
  加:期初现金及现金等价物余额1,537,235,613.621,537,237,583.641,595,165,053.711,595,165,053.71
  期末现金及现金等价物余额1,255,205,265.041,490,256,115.261,537,235,613.621,227,242,885.76
补充资料:
  净利润80,075,919.72-422,726,444.63-
  资产减值准备16,991,227.64-20,080,500.19-
  固定资产和投资性房地产折旧33,105,183.46-67,037,821.49-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧33,105,183.46-67,037,821.49-
  无形资产摊销3,187,290.67-8,270,050.87-
  长期待摊费用摊销366,311.12-651,149.45-
  处置固定资产、无形资产和其他长期资产的损失0--249,613.79-
  固定资产报废损失153,368.19-93,446.42-
  公允价值变动损失-1,033,638.05--2,105,592.51-
  财务费用2,089,203.38-2,268,891.66-
  投资损失-26,475,341.21--324,770,617.56-
  递延所得税---26,190,687.36-
  其中:递延所得税资产减少---25,144,691.32-
    递延所得税负债增加---1,045,996.04-
  存货的减少-18,448,814.37-11,279,585.29-
  经营性应收项目的减少-68,888,970.3-78,873,514.42-
  经营性应付项目的增加-67,381,328.34--30,470,666.72-
  其他--15,866,320.98-
  现金的期末余额1,255,205,265.04-1,537,235,613.62-
  减:现金的期初余额1,537,235,613.62-1,595,165,053.71-
  现金及现金等价物的净增加额-282,030,348.58--57,929,440.09-
公告日期2026-08-212026-04-242026-03-252025-10-24
审计意见(境内)标准无保留意见
TOP↑